BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31567534)

  • 1. Reactive oxygen species-regulating proteins peroxiredoxin 2 and thioredoxin, and glyceraldehyde-3-phosphate dehydrogenase are differentially abundant in induced sputum from smokers with lung cancer or asbestos exposure.
    Rostila AM; Anttila SL; Lalowski MM; Vuopala KS; Toljamo TI; Lindström I; Baumann MH; Puustinen AM
    Eur J Cancer Prev; 2020 May; 29(3):238-247. PubMed ID: 31567534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxiredoxins and tropomyosins as plasma biomarkers for lung cancer and asbestos exposure.
    Rostila A; Puustinen A; Toljamo T; Vuopala K; Lindström I; Nyman TA; Oksa P; Vehmas T; Anttila SL
    Lung Cancer; 2012 Aug; 77(2):450-9. PubMed ID: 22537621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer.
    Kettunen E; Salmenkivi K; Vuopala K; Toljamo T; Kuosma E; Norppa H; Knuutila S; Kaleva S; Huuskonen MS; Anttila S
    Lung Cancer; 2006 Nov; 54(2):169-76. PubMed ID: 16935392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of lung cancer with increasing time since ceasing exposure to asbestos and quitting smoking.
    Reid A; de Klerk NH; Ambrosini GL; Berry G; Musk AW
    Occup Environ Med; 2006 Aug; 63(8):509-12. PubMed ID: 16849527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose computed tomography screening for lung cancer in people with workplace exposure to asbestos.
    Maisonneuve P; Rampinelli C; Bertolotti R; Misotti A; Lococo F; Casiraghi M; Spaggiari L; Bellomi M; Novellis P; Solinas M; Dieci E; Alloisio M; Fontana L; Persechino B; Iavicoli S; Veronesi G
    Lung Cancer; 2019 May; 131():23-30. PubMed ID: 31027694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chest CT scan screening for lung cancer in asbestos occupational exposure: a systematic review and meta-analysis.
    Ollier M; Chamoux A; Naughton G; Pereira B; Dutheil F
    Chest; 2014 Jun; 145(6):1339-1346. PubMed ID: 24480869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early detection of central airway lung cancer in smokers with silicosis.
    Lo AI; Huang Y; Lam SY; Cheung AH; Au R; Leung CC; Lam WK; Ip MS; Chan-Yeung M; Lam B
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):523-7. PubMed ID: 21396213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals.
    Fitzgerald NR; Flanagan WM; Evans WK; Miller AB;
    Scand J Work Environ Health; 2015 Jul; 41(4):407-12. PubMed ID: 25837734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between exposure to asbestos and smoking jointly and the risk of lung cancer.
    Lee PN
    Occup Environ Med; 2001 Mar; 58(3):145-53. PubMed ID: 11171926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of effects on lung cancer of cigarette smoking and exposure in quebec chrysotile miners and millers.
    Liddell FD; Armstrong BG
    Ann Occup Hyg; 2002 Jan; 46(1):5-13. PubMed ID: 12005133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk.
    Schabath MB; Spitz MR; Delclos GL; Gunn GB; Whitehead LW; Wu X
    Am J Ind Med; 2002 Jul; 42(1):29-37. PubMed ID: 12111688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer screening an asbestos exposed population: Existing lung cancer risk criteria are not sufficient.
    Brims FJH; Harris EJA; Murray C; Kumarasamy C; Ho A; Adler B; Franklin P; de Klerk NH
    Respirology; 2023 Jun; 28(6):543-550. PubMed ID: 36889745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers.
    Omenn GS; Goodman G; Thornquist M; Grizzle J; Rosenstock L; Barnhart S; Balmes J; Cherniack MG; Cullen MR; Glass A
    Cancer Res; 1994 Apr; 54(7 Suppl):2038s-2043s. PubMed ID: 8137335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulation, asbestos, smoking habits, and lung cancer cell types.
    Muscat JE; Stellman SD; Wynder EL
    Am J Ind Med; 1995 Feb; 27(2):257-69. PubMed ID: 7755015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of the oxidative damage biomarker 8-epi-prostaglandin F2α to risk of lung cancer development in the Shanghai Cohort Study.
    Yuan JM; Carmella SG; Wang R; Tan YT; Adams-Haduch J; Gao YT; Hecht SS
    Carcinogenesis; 2018 Jul; 39(7):948-954. PubMed ID: 29726912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of lung cancer among former asbestos-exposed workers.
    Świątkowska B; Szubert Z; Sobala W; Szeszenia-Dąbrowska N
    Lung Cancer; 2015 Sep; 89(3):243-8. PubMed ID: 26126784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma.
    Andujar P; Pairon JC; Renier A; Descatha A; Hysi I; Abd-Alsamad I; Billon-Galland MA; Blons H; Clin B; Danel C; Debrosse D; Galateau-Sallé F; Housset B; Laurent-Puig P; Le Pimpec-Barthes F; Letourneux M; Monnet I; Régnard JF; Validire P; Zucman-Rossi J; Jaurand MC; Jean D
    Mutagenesis; 2013 May; 28(3):323-31. PubMed ID: 23435014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asbestos-associated genome-wide DNA methylation changes in lung cancer.
    Kettunen E; Hernandez-Vargas H; Cros MP; Durand G; Le Calvez-Kelm F; Stuopelyte K; Jarmalaite S; Salmenkivi K; Anttila S; Wolff H; Herceg Z; Husgafvel-Pursiainen K
    Int J Cancer; 2017 Nov; 141(10):2014-2029. PubMed ID: 28722770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs.
    Stresing V; Baltziskueta E; Rubio N; Blanco J; Arriba MC; Valls J; Janier M; Clézardin P; Sanz-Pamplona R; Nieva C; Marro M; Petrov D; Sierra A
    Oncogene; 2013 Feb; 32(6):724-35. PubMed ID: 22430214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis.
    Nelson HH; Christiani DC; Wiencke JK; Mark EJ; Wain JC; Kelsey KT
    Cancer Res; 1999 Sep; 59(18):4570-3. PubMed ID: 10493509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.